SCHEDULE: BAT Increases Stake in Charlotte's Web to 40.6%

Sentiment:

Schedule 13D Amendment


British American Tobacco has completed a strategic investment, increasing its ownership in Charlotte's Web Holdings to 40.6% through a private placement and debt conversion.

Capital raiseThe company raised C$13,873,000 through the private placement of 14,662,765 common shares.

Summary

  • BT DE Investments Inc., a subsidiary of British American Tobacco (BAT), completed an investment transaction on May 28, 2026.
  • The transaction involved the purchase of 14,662,765 common shares at C$0.94 per share for a total of C$13,873,000.
  • BAT converted its existing 5.00% senior unsecured convertible debenture into 95,281,277 common shares at a reduced conversion price of C$0.94.
  • Following these actions, BAT now beneficially owns 109,944,042 common shares, representing 40.6% of the issuer's outstanding stock.
  • The parties entered into an Amended and Restated Investor Rights Agreement granting BAT board nomination rights and governance protections.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral-to-positive development; while it provides necessary capital and debt relief, the significant dilution and increased control by a single entity may concern minority shareholders.

Positives

  • Strengthened strategic partnership with a major global entity (BAT).
  • Successful completion of a capital injection totaling C$13,873,000.
  • Reduction of debt burden through the conversion of the convertible debenture into equity.
  • Enhanced governance oversight with BAT securing board nomination rights.

Negatives

  • Significant dilution of existing shareholders due to the issuance of over 109 million new shares.
  • Increased concentration of ownership, with BAT now controlling 40.6% of the company.

Risks

  • Potential for future share price volatility due to the large block of shares held by a single entity.
  • Transfer restrictions and standstill provisions may limit liquidity and market flexibility for the next 18 to 24 months.
  • Governance rights granted to BAT may influence future strategic decisions in ways that might not align with all minority shareholders.

Future Outlook

The reporting person intends to review its investment on a continuing basis and may increase or decrease its ownership depending on market conditions and the terms of the Amended and Restated Investor Rights Agreement.

Management Comments

  • The Purchaser undertook the Investment as part of a strategic investment in the Issuer.
  • The Purchaser intends to review its investment in the Issuer on a continuing basis.

Industry Context

StockSavvy.ai notes that this move signals a deepening consolidation trend in the cannabis and wellness sector, where major tobacco and CPG players are securing long-term strategic footholds in smaller, specialized firms to hedge against traditional market declines.

Comparison to Industry Standards

  • The structure of the deal—combining a private placement with a debt-to-equity conversion—is a standard mechanism for distressed or capital-intensive growth companies to improve balance sheets.
  • The 40.6% ownership stake is significant and aligns with similar 'strategic investor' models seen in the broader consumer health and wellness space.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board RepresentationBAT granted the right to nominate up to 40% of the board of directors.2026-05-28Significant increase in influence over corporate strategy and oversight.

Stakeholder Impact

  • Shareholders: Significant dilution of equity interest.
  • Creditors: Improved balance sheet health due to debt conversion.
  • Management: Increased oversight and strategic alignment with a major shareholder.

Next Steps

  • Nomination of board members by BAT under the new rights agreement.
  • Ongoing monitoring of investment by BAT entities.
  • Potential future participation in equity offerings by BAT.

Key Dates

DateDescription
2022-11-14Original issuance of the convertible debenture and initial investor rights agreement.
2026-03-30Announcement of the subscription agreement and intent to convert debt.
2026-05-28Closing date of the investment transaction.
2026-05-29Filing date of Amendment No. 2 to Schedule 13D.

Recommendation

hold

The investment provides stability and capital, but the dilution and governance changes suggest a period of transition where investors should wait to see how the new board composition impacts operational performance.

Keywords

Charlotte's Web, British American Tobacco, Schedule 13D, Equity Investment, Convertible Debenture, Corporate Governance, CBD Industry

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.